A phase IIIb/IV randomized, controlled study evaluating an induction/maintenance treatment strategy of adding enfuvirtide [Fuzeon] to an oral highly active antiretroviral therapy in patients experienced with greater than or equal to 2 classes of antiretrovirals (ARVs) and with limited ARV experience

Trial Profile

A phase IIIb/IV randomized, controlled study evaluating an induction/maintenance treatment strategy of adding enfuvirtide [Fuzeon] to an oral highly active antiretroviral therapy in patients experienced with greater than or equal to 2 classes of antiretrovirals (ARVs) and with limited ARV experience

Not stated
Phase of Trial: Phase III

Latest Information Update: 10 Jul 2006

At a glance

  • Drugs Antiretrovirals; Enfuvirtide
  • Indications HIV infections
  • Focus Therapeutic Use
  • Acronyms INTENSE
  • Most Recent Events

    • 10 Jul 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top